Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma
Madeleine Sassenberg(Heinrich Heine University Düsseldorf), Michèle J. Hoffmann(University Hospital of Bern)
Cited by 47
Related Papers
Expression Profile of the Polycomb Group Protein Enhancer of Zeste Homologue 2 and its Prognostic Relevance in Renal Cell Carcinoma
|The Journal of Urology|2009|50
Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder
|Journal of Cancer Research and Clinical Oncology|2007|38
Predictive value of molecular subtypes and <i>APOBEC3G</i> for adjuvant chemotherapy in urothelial bladder cancer
|Cancer Medicine|2022|14
A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer—Stromal gene expressions show higher prognostic values than intrinsic tumor genes
|International Journal of Cancer|2021|9
6. Symposium des Deutschen Forschungsverbunds Blasenkarzinom
|Der Urologe|2017|0